JP2003523735A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003523735A5 JP2003523735A5 JP2001538509A JP2001538509A JP2003523735A5 JP 2003523735 A5 JP2003523735 A5 JP 2003523735A5 JP 2001538509 A JP2001538509 A JP 2001538509A JP 2001538509 A JP2001538509 A JP 2001538509A JP 2003523735 A5 JP2003523735 A5 JP 2003523735A5
- Authority
- JP
- Japan
- Prior art keywords
- isolated
- seq
- antibody
- cells
- biological sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44051499A | 1999-11-15 | 1999-11-15 | |
| CA2288307A CA2288307C (en) | 1999-11-15 | 1999-11-15 | Novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify the same |
| US09/440,514 | 1999-11-15 | ||
| CA2,288,307 | 1999-11-15 | ||
| PCT/EP2000/011697 WO2001036630A2 (en) | 1999-11-15 | 2000-11-15 | Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2003523735A JP2003523735A (ja) | 2003-08-12 |
| JP2003523735A5 true JP2003523735A5 (https=) | 2008-01-17 |
| JP4776845B2 JP4776845B2 (ja) | 2011-09-21 |
Family
ID=25681295
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001538509A Expired - Fee Related JP4776845B2 (ja) | 1999-11-15 | 2000-11-15 | ヒトナチュラルキラー細胞によって媒介される天然細胞毒性に関連した新規トリガリングレセプターおよび同一の性質を有する抗体 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1240326B1 (https=) |
| JP (1) | JP4776845B2 (https=) |
| AT (1) | ATE423848T1 (https=) |
| AU (1) | AU783899B2 (https=) |
| DE (1) | DE60041655D1 (https=) |
| DK (1) | DK1240326T3 (https=) |
| ES (1) | ES2321687T3 (https=) |
| WO (1) | WO2001036630A2 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10261223A1 (de) * | 2002-12-20 | 2004-07-08 | MedInnova Gesellschaft für medizinische Innovationen aus akademischer Forschung mbH | Steigerung der Immunantwort durch Substanzen, welche die Funktion von Natürlichen Killerzellen beeinflussen |
| EP1575615A1 (en) * | 2002-12-23 | 2005-09-21 | Innate Pharma | Pharmaceutical compositions having an effect on the proliferation of nk cells and a method using the same |
| EP1445614A1 (en) * | 2003-02-06 | 2004-08-11 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | A method for the in vitro assessment of the progression status of an HIV virus in an invidual |
| HRP20170342T1 (hr) | 2003-07-24 | 2017-05-19 | Innate Pharma S.A. | Metode i sastavi za povećanje učinkovitosti terapijskih protutijela koristeći tvari koje potenciraju nk stanice |
| US20070178106A1 (en) * | 2004-04-30 | 2007-08-02 | Innate Pharma, S.A. | Compositions and methods for enhancing nk cell activity |
| US20080199423A1 (en) * | 2004-06-18 | 2008-08-21 | Genentech, Inc. | Methods of Using Apo2l Receptor Agonists and Ink Cell Activators |
| DK1773884T3 (da) | 2004-08-03 | 2012-05-21 | Innate Pharma | Terapeutiske og diagnostiske fremgangsmåder og sammensætninger til targeting af 4ig-b7-h3 og dets tilsvarende nk-celle-receptor |
| EP1626059A1 (en) * | 2004-08-09 | 2006-02-15 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Angiogenic and immunologic applications of anti-CD160 specific compounds obtainable from mAb CL1-R2 |
| PT1831258E (pt) | 2004-12-28 | 2016-01-07 | Univ Genova | Anticorpos monoclonais contra nkg2a |
| CN101300272B (zh) | 2005-10-14 | 2013-09-18 | 依奈特制药公司 | 用于治疗增生性病症的组合物和方法 |
| CN102099055A (zh) * | 2007-10-04 | 2011-06-15 | 津莫吉尼蒂克斯公司 | B7家族成员zB7H6及相关的组合物和方法 |
| US10736963B2 (en) * | 2015-07-24 | 2020-08-11 | Innate Pharma | Methods for detecting tissue infiltrating NK cells |
| EP3713959A1 (en) | 2017-11-21 | 2020-09-30 | Innate Pharma | Multispecific antigen binding proteins |
| US12247060B2 (en) | 2018-01-09 | 2025-03-11 | Marengo Therapeutics, Inc. | Calreticulin binding constructs and engineered T cells for the treatment of diseases |
| CA3105448A1 (en) | 2018-07-03 | 2020-01-09 | Elstar Therapeutics, Inc. | Anti-tcr antibody molecules and uses thereof |
| GB2599228B (en) | 2019-02-21 | 2024-02-07 | Marengo Therapeutics Inc | Multifunctional molecules that bind to T cell related cancer cells and uses thereof |
| CN119039441A (zh) | 2019-02-21 | 2024-11-29 | 马伦戈治疗公司 | 与nkp30结合的抗体分子及其用途 |
| AU2020416273A1 (en) | 2020-01-03 | 2022-07-28 | Marengo Therapeutics, Inc. | Anti-TCR antibody molecules and uses thereof |
| US20250051440A1 (en) | 2021-12-14 | 2025-02-13 | Institut National de la Santé et de la Recherche Médicale | Depletion of nk cells for the treatment of adverse post-ischemic cardiac remodeling |
| JP7821427B2 (ja) * | 2022-01-27 | 2026-02-27 | 学校法人 東洋大学 | ナチュラルキラー細胞活性の測定方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2170352A1 (en) * | 1993-08-27 | 1995-03-02 | Paul Anderson | Natural killer cell-specific antigen and antibodies that identify the same |
| WO1999023867A2 (en) * | 1997-11-07 | 1999-05-20 | Biogen, Inc. | Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use |
| WO1999049881A2 (de) * | 1998-03-27 | 1999-10-07 | Gabriele Multhoff | Verwendung von hsp70 protein |
-
2000
- 2000-11-15 ES ES00989877T patent/ES2321687T3/es not_active Expired - Lifetime
- 2000-11-15 JP JP2001538509A patent/JP4776845B2/ja not_active Expired - Fee Related
- 2000-11-15 AU AU26677/01A patent/AU783899B2/en not_active Ceased
- 2000-11-15 EP EP00989877A patent/EP1240326B1/en not_active Expired - Lifetime
- 2000-11-15 DK DK00989877T patent/DK1240326T3/da active
- 2000-11-15 DE DE60041655T patent/DE60041655D1/de not_active Expired - Lifetime
- 2000-11-15 AT AT00989877T patent/ATE423848T1/de active
- 2000-11-15 WO PCT/EP2000/011697 patent/WO2001036630A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2003523735A5 (https=) | ||
| DE69325577T2 (de) | Mn-gen und protein | |
| JPH09505723A (ja) | ４３ｋｄヒトガン抗原からの免疫反応性ペプチド配列 | |
| JP2007532139A5 (https=) | ||
| WO1998055621A1 (en) | Ntn-2 member of tnf ligand family | |
| JP4776845B2 (ja) | ヒトナチュラルキラー細胞によって媒介される天然細胞毒性に関連した新規トリガリングレセプターおよび同一の性質を有する抗体 | |
| US6979546B2 (en) | Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify the same | |
| KR20210087458A (ko) | 고형 종양 치료를 위한 조작된 및 비-조작된 γδ-T 세포에 관한 조성물 및 방법 | |
| JP2003525566A (ja) | １２５個のヒト分泌タンパク質 | |
| CN1146576C (zh) | 得自哺乳动物肝脏的蛋白质及其在肿瘤学中的应用 | |
| US8071716B2 (en) | Thymus-specific protein | |
| JP2023526218A (ja) | 生体高分子標的特異的補体阻害剤及びその製造方法と応用 | |
| TW202306971A (zh) | 用於治療視神經脊髓炎之肽及方法 | |
| US20070148686A1 (en) | Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof | |
| JP3231262B2 (ja) | ヒトＴｈ１特異的タンパク質及びこれをコードする遺伝子、並びにこれに関連する形質転換体、組換えベクター及び抗体 | |
| CA2104997A1 (en) | Bone-related cadherin-like protein and process for its production | |
| WO1998029448A1 (en) | Human pathogenesis-related protein | |
| JP2000515726A (ja) | 分泌蛋白をコードする成人ｐｂｍｃ由来のポリヌクレオチド | |
| JP2002504361A (ja) | ３６個のヒト分泌タンパク質 | |
| GB2375540A (en) | Vertebrate globin | |
| CA2262412A1 (en) | Porcine leptin protein, nucleic acid sequences coding therefor and uses thereof | |
| JP2004518410A5 (https=) | ||
| EP4512410A1 (en) | Novel-peptide-based anticancer immunotherapeutic agent | |
| KR102689877B1 (ko) | CD300c 항원 또는 그의 수용체에 특이적으로 결합하는 키메라 항원 수용체 | |
| JPH03502446A (ja) | 動物およびヒトのレクチン類の少なくとも一部分の配列を再現するアミノ酸配列，それを得る方法，およびその診断および治療への用途 |